158 related articles for article (PubMed ID: 23928116)
1. Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics.
Konialis C; Savola S; Karapanou S; Markaki A; Karabela M; Polychronopoulou S; Ampatzidou M; Voulgarelis M; Viniou NA; Variami E; Koumarianou A; Zoi K; Hagnefelt B; Schouten JP; Pangalos C
Hematology; 2014 Jun; 19(4):217-24. PubMed ID: 23928116
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
[TBL] [Abstract][Full Text] [Related]
3. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
[TBL] [Abstract][Full Text] [Related]
4. Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia.
Coll-Mulet L; Santidrián AF; Cosialls AM; Iglesias-Serret D; de Frias M; Grau J; Menoyo A; González-Barca E; Pons G; Domingo A; Gil J
Br J Haematol; 2008 Sep; 142(5):793-801. PubMed ID: 18564355
[TBL] [Abstract][Full Text] [Related]
5. Uncovering recurrent microdeletion syndromes and subtelomeric deletions/duplications through non-selective application of a MLPA-based extended prenatal panel in routine prenatal diagnosis.
Konialis C; Hagnefelt B; Sevastidou S; Karapanou S; Pispili K; Markaki A; Pangalos C
Prenat Diagn; 2011 Jun; 31(6):571-7. PubMed ID: 21448863
[TBL] [Abstract][Full Text] [Related]
6. High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia.
Othman MA; Melo JB; Carreira IM; Rincic M; Glaser A; Grygalewicz B; Gruhn B; Wilhelm K; Rittscher K; Meyer B; Silva ML; de Jesus Marques Salles T; Liehr T
Mol Cytogenet; 2015; 8():45. PubMed ID: 26136832
[TBL] [Abstract][Full Text] [Related]
7. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
8. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification.
Stevens-Kroef M; Simons A; Gorissen H; Feuth T; Weghuis DO; Buijs A; Raymakers R; Geurts van Kessel A
Cancer Genet Cytogenet; 2009 Dec; 195(2):97-104. PubMed ID: 19963108
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH).
Alhourani E; Rincic M; Othman MA; Pohle B; Schlie C; Glaser A; Liehr T
Mol Cytogenet; 2014; 7(1):79. PubMed ID: 25435911
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases.
Ashok V; Ranganathan R; Chander S; Damodar S; Bhat S; S NK; A SK; Jadav SS; Rajashekaraiah M; T S S
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3457-3464. PubMed ID: 29286619
[TBL] [Abstract][Full Text] [Related]
11. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
Fabris S; Scarciolla O; Morabito F; Cifarelli RA; Dininno C; Cutrona G; Matis S; Recchia AG; Gentile M; Ciceri G; Ferrarini M; Ciancio A; Mannarella C; Neri A; Fragasso A
Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
[TBL] [Abstract][Full Text] [Related]
12. Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients.
Ma J; Ai X; Wang J; Xing L; Tian C; Yang H; Yu Y; Zhao H; Wang X; Zhao Z; Wang Y; Cao Z
Ann Hematol; 2021 Sep; 100(9):2207-2214. PubMed ID: 33990890
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
14. Oligo-based High-resolution aCGH Analysis Enhances Routine Cytogenetic Diagnostics in Haematological Malignancies.
Kjeldsen E
Cancer Genomics Proteomics; 2015; 12(6):301-37. PubMed ID: 26543079
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of MLPA as a comprehensive molecular cytogenetic tool to detect cytogenetic markers of chronic lymphocytic leukemia in Egyptian patients.
Eid OM; Abdel Kader RMA; Fathalla LA; Abdelrahman AH; Rabea A; Mahrous R; Eid MM
J Genet Eng Biotechnol; 2021 Jun; 19(1):98. PubMed ID: 34181122
[TBL] [Abstract][Full Text] [Related]
16. MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q.
Vorstman JA; Jalali GR; Rappaport EF; Hacker AM; Scott C; Emanuel BS
Hum Mutat; 2006 Aug; 27(8):814-21. PubMed ID: 16791841
[TBL] [Abstract][Full Text] [Related]
17. Whole genome scanning as a cytogenetic tool in hematologic malignancies.
Maciejewski JP; Mufti GJ
Blood; 2008 Aug; 112(4):965-74. PubMed ID: 18505780
[TBL] [Abstract][Full Text] [Related]
18. Detection of cryptic subtelomeric chromosome abnormalities and identification of anonymous chromatin using a quantitative multiplex ligation-dependent probe amplification (MLPA) assay.
Northrop EL; Ren H; Bruno DL; McGhie JD; Coffa J; Schouten J; Choo KH; Slater HR
Hum Mutat; 2005 Nov; 26(5):477-86. PubMed ID: 16170807
[TBL] [Abstract][Full Text] [Related]
19. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
Moosavi SA; Sanchez J; Adeyinka A
Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
[TBL] [Abstract][Full Text] [Related]
20. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
Maciejewski JP; Tiu RV; O'Keefe C
Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
